Ingrid Hopper

6.7k total citations · 1 hit paper
104 papers, 2.1k citations indexed

About

Ingrid Hopper is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Cancer Research. According to data from OpenAlex, Ingrid Hopper has authored 104 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 34 papers in Surgery and 13 papers in Cancer Research. Recurrent topics in Ingrid Hopper's work include Heart Failure Treatment and Management (30 papers), Breast Implant and Reconstruction (19 papers) and Breast Cancer Treatment Studies (13 papers). Ingrid Hopper is often cited by papers focused on Heart Failure Treatment and Management (30 papers), Breast Implant and Reconstruction (19 papers) and Breast Cancer Treatment Studies (13 papers). Ingrid Hopper collaborates with scholars based in Australia, United States and United Kingdom. Ingrid Hopper's co-authors include Henry Krum, Marina Skiba, Danny Liew, Julia Gilmartin‐Thomas, Thomas G. von Lueder, Rodney D. Cooter, Baki Billah, Christopher M. Reid, John J. McNeil and William Kemp and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Ingrid Hopper

100 papers receiving 2.1k citations

Hit Papers

Long-term efficacy and safety of renal denervation in the... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
    2022 168 citations Ingrid Hopper et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Hopper Australia 26 875 686 331 222 191 104 2.1k
Piotr Jankowski Poland 26 1.4k 1.6× 589 0.9× 244 0.7× 101 0.5× 198 1.0× 211 2.4k
S.J.H. Bredie Netherlands 28 835 1.0× 975 1.4× 555 1.7× 130 0.6× 296 1.5× 82 2.5k
Meral Kayıkçıoğlu Türkiye 22 931 1.1× 686 1.0× 252 0.8× 90 0.4× 136 0.7× 116 1.8k
Anurag Mehta United States 27 933 1.1× 841 1.2× 668 2.0× 175 0.8× 184 1.0× 139 2.6k
Pankaj Arora United States 28 1.1k 1.3× 447 0.7× 189 0.6× 80 0.4× 242 1.3× 154 2.4k
Moshe Hoshen Israel 21 353 0.4× 303 0.4× 163 0.5× 273 1.2× 225 1.2× 67 1.7k
Desidério Favarato Brazil 22 829 0.9× 666 1.0× 269 0.8× 47 0.2× 113 0.6× 75 1.6k
Xiaojuan Mi United States 25 1.5k 1.7× 359 0.5× 361 1.1× 99 0.4× 501 2.6× 54 2.4k
Gavin J. Blake United States 19 806 0.9× 767 1.1× 547 1.7× 266 1.2× 251 1.3× 33 2.4k
Stacey Knight United States 24 552 0.6× 330 0.5× 197 0.6× 76 0.3× 130 0.7× 108 2.0k

Countries citing papers authored by Ingrid Hopper

Since Specialization
Citations

This map shows the geographic impact of Ingrid Hopper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Hopper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Hopper more than expected).

Fields of papers citing papers by Ingrid Hopper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Hopper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Hopper. The network helps show where Ingrid Hopper may publish in the future.

Co-authorship network of co-authors of Ingrid Hopper

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Hopper. A scholar is included among the top collaborators of Ingrid Hopper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Hopper. Ingrid Hopper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dennis, Adelaide S. M., et al.. (2024). Palliative Care Utilisation and Outcomes in Patients Admitted for Heart Failure in a Victorian Healthcare Service. Heart Lung and Circulation. 33(7). 1058–1066. 2 indexed citations
3.
Aung, Ar Kar, et al.. (2024). General physicians' perspectives on SGLT2 inhibitors for heart failure. Internal Medicine Journal. 54(9). 1483–1489. 2 indexed citations
4.
Earnest, Arul, et al.. (2024). Patient-Reported Outcome Measures in High-Risk Medical Device Registries: A Scoping Review. SHILAP Revista de lepidopterología. 6. ojae015–ojae015. 1 indexed citations
5.
Driscoll, Andrea, Diem Dinh, Angela Brennan, et al.. (2024). Comparison of Characteristics and Outcomes in Patients With Acute Decompensated Heart Failure Admitted Under General Medicine and Cardiology Units. Heart Lung and Circulation. 33(7). 983–989. 1 indexed citations
6.
Zoungas, Sophia, Chris Moran, Andrea J. Curtis, et al.. (2024). Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability‐Free Survival in Older People. Journal of the American Heart Association. 13(22). e036357–e036357. 4 indexed citations
7.
8.
Digby, Robin, et al.. (2023). Exploring staff perspectives on caring for isolated hospitalised patients during the COVID-19 pandemic: a qualitative study. BMC Health Services Research. 23(1). 208–208. 2 indexed citations
9.
Ruseckaite, Rasa, et al.. (2022). Patient Reported Outcome Measures After Breast Augmentation – Using the BREAST-Q IS. Dove Medical Press (Taylor and Francis Group). 4 indexed citations
10.
Ahern, Susannah, et al.. (2021). Identification of Predictive Factors for Patient-Reported Outcomes in the Prospective Australian Breast Device Registry. Aesthetic Surgery Journal. 42(5). 470–480. 4 indexed citations
11.
Hopper, Ingrid, James C. Campbell, Lucy Busija, et al.. (2020). Impact of a model of care for heart failure in‐patients to reduce variation in care: a quality improvement project. Internal Medicine Journal. 51(4). 557–564. 3 indexed citations
12.
Parker, Emily Anne, et al.. (2020). Test-Retest Reliability of the BREAST-Q IS in the Australian Breast Device Registry. Aesthetic Surgery Journal. 41(4). NP177–NP184. 5 indexed citations
13.
Wang, Zhiqiang, Graeme Jones, Tania Winzenberg, et al.. (2020). Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion–Synovitis of Knee Osteoarthritis. Annals of Internal Medicine. 173(11). 861–869. 73 indexed citations
14.
Cartledge, Susie, et al.. (2020). The Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study. JMIR mhealth and uhealth. 8(12). e18496–e18496. 3 indexed citations
15.
Ahern, Susannah, Ingrid Hopper, & Erwin Loh. (2019). Qualified privilege legislation to support clinician quality assurance: balancing professional and public interests. The Medical Journal of Australia. 210(8). 343–343. 5 indexed citations
16.
Kirkman, Maggie, Jane Fisher, Andrea L. Pusic, et al.. (2019). Establishing the acceptability of a brief patient reported outcome measure and feasibility of implementing it in a breast device registry – a qualitative study. Journal of Patient-Reported Outcomes. 3(1). 63–63. 12 indexed citations
17.
Batchelor, R., et al.. (2018). Systematic review with meta‐analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel. Alimentary Pharmacology & Therapeutics. 48(8). 780–796. 51 indexed citations
18.
Hopper, Ingrid, et al.. (2017). Australian Breast Device Registry: breast device safety transformed. ANZ Journal of Surgery. 87(1-2). 9–10. 19 indexed citations
19.
Ahern, Susannah, et al.. (2017). Cosmetic tourism for breast augmentation: a systematic review. ANZ Journal of Surgery. 88(9). 842–847. 17 indexed citations
20.
Hopper, Ingrid, Marina Skiba, & Henry Krum. (2012). Updated Meta-Analysis on Antithrombotic Therapy in Patients with Heart Failure and Sinus Rhythm. European Journal of Heart Failure. 15(1). 69–78. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piotr Jankowski Breakdown of academic impact, for papers by S.J.H. Bredie Breakdown of academic impact, for papers by Meral Kayıkçıoğlu Breakdown of academic impact, for papers by Anurag Mehta Breakdown of academic impact, for papers by Pankaj Arora Breakdown of academic impact, for papers by Moshe Hoshen Breakdown of academic impact, for papers by Desidério Favarato Breakdown of academic impact, for papers by Xiaojuan Mi Breakdown of academic impact, for papers by Gavin J. Blake Breakdown of academic impact, for papers by Stacey Knight
Rankless by CCL
2026